Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Analysts Set Co-Diagnostics, Inc. (NASDAQ:CODX) PT at $1.83
01:12am, Saturday, 29'th Nov 2025
Shares of Co-Diagnostics, Inc. (NASDAQ: CODX - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are currently covering the stock, MarketBeat reports. O
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
09:00am, Thursday, 20'th Nov 2025
SALT LAKE CITY , Nov. 20, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of m
SALT LAKE CITY , Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of m
Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript
07:01pm, Thursday, 13'th Nov 2025
Co-Diagnostics, Inc. ( CODX ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman & CEO Brian Brown - CFO & Compa
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates
06:16pm, Thursday, 13'th Nov 2025
Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.32 per share a year ago.
Co-Diagnostics Reports Third Quarter 2025 Financial Results
04:01pm, Thursday, 13'th Nov 2025
SALT LAKE CITY , Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for t
Co-Diagnostics, Inc. (CODX) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments Transcript
10:51pm, Wednesday, 05'th Nov 2025
Co-Diagnostics, Inc. ( CODX ) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments November 5, 2025 11:00 AM EST Company Participants Dwight Egan - Chairman & C
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
09:00am, Wednesday, 05'th Nov 2025
SALT LAKE CITY , Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
09:00am, Monday, 03'rd Nov 2025
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx's existing and future AI initiatives SALT LAKE CITY , Nov. 3, 2025 /PRNewswire
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
09:00am, Friday, 31'st Oct 2025
SALT LAKE CITY , Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests
SALT LAKE CITY , Oct. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
12:51pm, Wednesday, 29'th Oct 2025
SALT LAKE CITY , Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of
SALT LAKE CITY , Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
08:30am, Wednesday, 22'nd Oct 2025
Conference attendance follows recent MOU announcement for a joint venture with a regional manufacturing and distribution company in the Kingdom of Saudi Arabia SALT LAKE CITY , Oct. 22, 2025 /PRNewswi
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing
09:30am, Thursday, 16'th Oct 2025
New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics SAL
